What is Omni Health Inc?
, through its subsidiary, Malecon Pharmacy, Inc.
OMHE · Verdict
Solid reward · moderate risk
OMHE scores well on volatility and growth with no major weaknesses flagged in the model.
Based on 88% data coverage
OMHE · Verdict
Top decile vs peers
Revenue +253.4% CAGR
Current ratio 1.25
Model-based scoring. For information only — not financial advice.
, through its subsidiary, Malecon Pharmacy, Inc. , operates a pharmacy in Hialeah, Florida. The company is listed on the OTCCE in USA, operating in the Healthcare sector, with a market capitalisation of 29.29K.
The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.